The complex molecular underpinnings of genetic and rare diseases offer a promising avenue for scientific exploration and ...
Physical activity (PA) and sedentary behaviour (SB) present critical challenges and opportunities in the field of public health, where targeted strategies ...
The VISIONARY trial is testing sibeprenlimab, a humanized IgG2 monoclonal antibody, in patients with IgA nephropathy, a population at high risk for kidney failure.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback